Dr. Chadwick Davis

Recursion Pharmaceuticals

Chad has extensive training in molecular biology, genetics, and infectious disease.  He completed his Ph.D. under the guidance of Dr. Dean Y. Li at the University of Utah where he published exciting work on inflammatory signaling and vascular biology, including the evaluation of potential therapeutics for the treatment of inflammatory conditions such as arthritis, ARDS, and sepsis.  Chad contributes to the planning and execution of core research at Recursion Pharmaceuticals, and also heads the company’s budding programs in revolutionary screening strategies for infectious disease.

Join our community